Omnilife Science, INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$6.3Mgeneral payments (2019-2025)
$415Kresearch payments (2019-2025)
482clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $642K
2020 $1.1M
2021 $995K
2022 $879K
2023 $775K
2024 $1.2M
2025 $789K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery $3.6M
Adult Reconstructive Orthopaedic Surgery $1.2M
Sports Medicine (Orthopaedic Surgery) $126K
Surgery $17K
Physician Assistant $4,288
Orthopaedic Trauma $3,096

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Jan Koenig Rockville Centre, NY $1,396,901.59
Stefan Kreuzer Houston, TX Orthopaedic Surgery $981,983.66
Juan Suarez Miami, FL Adult Reconstructive Orthopaedic Surgery $367,460.21
Charles Toulson Mckinney, TX Orthopaedic Surgery $326,362.21
Jeffrey Lawrence Viroqua, WI Orthopaedic Surgery $251,942.45
Stephen Raterman Tampa, FL Orthopaedic Surgery $251,552.42
Vasili Karas Chicago, IL Adult Reconstructive Orthopaedic Surgery $202,695.42
William Tucker Addison, TX Orthopaedic Surgery $189,504.89
John Keggi Middlebury, CT Orthopaedic Surgery $158,178.38
Corey Ponder Oklahoma City, OK Adult Reconstructive Orthopaedic Surgery $139,213.34

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.